Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation.

MLA

Romero R, et al. “Soluble Receptor for Advanced Glycation End Products (SRAGE) and Endogenous Secretory RAGE (EsRAGE) in Amniotic Fluid: Modulation by Infection and Inflammation.” Journal of Perinatal Medicine, vol. 36, no. 5, Sept. 2008, pp. 388–98. EBSCOhost, https://doi.org/10.1515/jpm.2008.076.

APA

Romero R, Espinoza J, Hassan S, Gotsch F, Kusanovic JP, Avila C, Erez O, Edwin S, & Schmidt AM. (2008). Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation. Journal of Perinatal Medicine, 36(5), 388–398. https://doi.org/10.1515/jpm.2008.076

Chicago

Romero R, Espinoza J, Hassan S, Gotsch F, Kusanovic JP, Avila C, Erez O, Edwin S, and Schmidt AM. 2008. “Soluble Receptor for Advanced Glycation End Products (SRAGE) and Endogenous Secretory RAGE (EsRAGE) in Amniotic Fluid: Modulation by Infection and Inflammation.” Journal of Perinatal Medicine 36 (5): 388–98. doi:10.1515/jpm.2008.076.